MMSI · Merit Medical Systems, Inc.

Merit Medical Systems, Inc. reported solid Q1 2026 results, with revenue of $381.9 million marking a 7.5% increase over $355.4 million in the prior-year quarter. This growth reflects sustained product demand across the company's medical device portfolio, enabling topline expansion that drove key profitability metrics higher. Gross profit reached $184.8 million, up 7.4% from $172.0 million, holding gross margin steady at 48.4%. This stability stems from the balance between revenue gains and cost of sales, underscoring efficient scaling of production to meet demand without margin erosion.

Operating income advanced 7.6% to $44.2 million from $41.0 million, primarily attributable to the higher sales base as noted in management discussion. This leverage was partially offset by elevated selling, general, and administrative expenses, driven by investments in preparation for the pending View Point acquisition, company conferences, and ongoing operational needs. These expenditures highlight management's commitment to strategic growth, including facility enhancements and market expansion, even as they tempered operating margin at 11.6%.

Net income saw outsized 36.0% growth to $41.0 million from $30.1 million, with diluted EPS rising 38.8% to $0.68 from $0.49. The acceleration beyond operating trends points to favorable other income contributions, including gains from recent divestiture activity. However, the effective tax rate increased due to reduced benefits from discrete items like share-based compensation and tax effects of acquisitions and divestitures, alongside higher pre-tax income. This dynamic illustrates how one-time portfolio adjustments amplified bottom-line results while tax normalization provided a counterbalance.

Cash generation remained robust, with net cash from operating activities at $40.7 million, nearly flat with the prior period despite net income growth. Working capital shifts, such as inventory builds to support sales momentum, offset some gains. Capital expenditures fell to $16.0 million from $21.1 million, focused on property and equipment for product development, production capacity, and construction of a new distribution facility in South Jordan, Utah. This discipline yielded free cash flow of $24.7 million, bolstering liquidity.